Brief: Dermata Therapeutics Inc - On June 4 Got Letter From Nasdaq That Company Has Regained Compliance With Minimum Bid Price Requirement
05/06/2024 14:12
June 5 (Reuters) - Dermata Therapeutics Inc DRMA.O :
* DERMATA THERAPEUTICS INC - ON JUNE 4 GOT LETTER FROM
NASDAQ
THAT COMPANY HAS REGAINED COMPLIANCE WITH MINIMUM BID PRICE
REQUIREMENT
Source text for Eikon: ID:n0001654954-24-007369
Further company coverage: DRMA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dermata Therapeutics
See all newsNASDAQ RESUMED AT 10:31 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:26 AM
Brief: Dermata Therapeutics - To Launch First Commercial Product Tome Foundational Treatment On August 25, 2026
Dermata Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Dermata Therapeutics Inc expected to post a loss of 55 cents a share - Earnings Preview